|
APPBP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.68514116391816E-14 |
| Normal-vs-Stage2 |
2.07150000000045E-05 |
| Normal-vs-Stage3 |
9.54791801177635E-15 |
| Normal-vs-Stage4 |
5.99520433297585E-15 |
| Stage1-vs-Stage2 |
1.209220E-01 |
| Stage1-vs-Stage3 |
5.595800E-02 |
| Stage1-vs-Stage4 |
4.397600E-04 |
| Stage2-vs-Stage3 |
7.241400E-03 |
| Stage2-vs-Stage4 |
3.007300E-04 |
| Stage3-vs-Stage4 |
1.397190E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.010030E-04 |
| Normal-vs-Asian |
1.4120999924927E-09 |
| Caucasian-vs-AfricanAmerican |
2.298200E-01 |
| Caucasian-vs-Asian |
8.905000E-01 |
| AfricanAmerican-vs-Asian |
3.319800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.55351295663786E-15 |
| Normal-vs-Female |
1.63036251166204E-12 |
| Male-vs-Female |
2.552000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.0820901386619E-12 |
| Normal-vs-Age(41-60Yrs) |
9.1926466438963E-14 |
| Normal-vs-Age(61-80Yrs) |
2.01261229904048E-12 |
| Normal-vs-Age(81-100Yrs) |
5.230800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.759400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.059600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.635800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.394600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.370000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.710800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.979400E-04 |
| Classical-VS-Follicular |
3.088400E-01 |
| Classical-VS-Other |
1.507560E-01 |
| Classical-VS-Normal |
1.6304735339645E-12 |
| Tall-VS-Follicular |
1.769660E-04 |
| Tall-VS-Other |
9.031200E-01 |
| Tall-VS-Normal |
4.90718576884319E-14 |
| Follicular-VS-Other |
1.239030E-01 |
| Follicular-VS-Normal |
7.10059999686763E-08 |
| Other-VS-Normal |
1.174730E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.46502818157524E-12 |
| Normal-vs-N1 |
2.52797782707148E-12 |
| N0-vs-N1 |
2.867700E-02 |
|
|
